PAM
RCKT icon

Premier Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Premier Asset Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,710
Closed -$209K – 206
2021
Q1 		$209K Buy
+4,710
New +$259K 0.04% 183

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Premier Asset Management's RCKT Position: Q2 2021 in Review

Premier Asset Management sold out of Rocket Pharmaceuticals (RCKT) in Q2 2021, closing a stake of 4,710 shares — an estimated $209K sold.

Premier Asset Management first reported a position in RCKT in Q1 2021 and held it in 1 quarter. The position peaked at $209K in Q1 2021. 150 funds tracked by Wall St. Rank hold RCKT as of Q2 2021.

  • Premier Asset Management reported no remaining Rocket Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Premier Asset Management sold 4,710 Rocket Pharmaceuticals shares in Q2 2021, an estimated $209K.
  • Premier Asset Management first reported a position in Rocket Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Premier Asset Management's Rocket Pharmaceuticals position peaked at $209K in Q1 2021.
  • 150 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2021.

Based on Premier Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.